Bioregenx (BRGX) Restructuring Costs (2022 - 2023)
Bioregenx's (BRGX) quarterly Restructuring Costs came in at $6193.0 in Q4 2023, down 8.43% year-on-year from $6763.0 in Q4 2022, and up 517.45% quarter-over-quarter from $1003.0 in Q3 2023.
Bioregenx (BRGX) Restructuring Costs (2022 - 2023) Analysis & Trends
Bioregenx's Restructuring Costs history runs 2 years deep, the most recent figure standing at $6193.0 for Q4 2023.
- On a quarterly basis, Restructuring Costs fell 8.43% year-over-year to $6193.0 in Q4 2023; TTM through Dec 2023 was $18254.0, a 33.97% decrease from a year earlier, with the FY2023 full-year figure at $18254.0, down 33.97% from the prior year.
- Restructuring Costs advanced to $6193.0 in Q4 2023 per BRGX's latest filing, from $1003.0 in the prior quarter.
- Across five years, Restructuring Costs topped out at $9168.0 in Q1 2023 and bottomed at $1003.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 29.34 Bn | 22.03 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 13.49 Bn | 12.59 Bn | 482.22 Mn |
| 3 | Healthequity | 7.96 Bn | 7.70 Bn | 256.31 Mn |
| 4 | 10x Genomics | 6.17 Bn | 5.63 Bn | 106.18 Mn |
| 5 | Hinge Health | 6.02 Bn | 5.70 Bn | 154.23 Mn |
| 6 | MiniMed | 4.19 Bn | 3.89 Bn | 480.00 Mn |
| 7 | Waystar Holding | 4.14 Bn | 4.07 Bn | 216.84 Mn |
| 8 | Doximity | 3.82 Bn | 3.08 Bn | 125.97 Mn |
| 9 | Privia Health | 3.10 Bn | 2.73 Bn | - |
| 10 | Bioregenx | 9.69 Mn | 9.65 Mn | 348,288.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 6,193.00 |
| Sep 30, 2023 | 1,003.00 |
| Jun 30, 2023 | 1,890.00 |
| Mar 31, 2023 | 9,168.00 |
| Dec 31, 2022 | 6,763.00 |
| Sep 30, 2022 | 6,374.00 |
| Jun 30, 2022 | 7,888.00 |
| Mar 31, 2022 | 6,622.00 |